Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aldehyde dehydrogenase 8 family member A1 (ALDH8A1) is a human enzyme coded by the ALDH8A1 gene. It is classified in the aldehyde dehydrogenase superfamily, responsible for oxidizing aldehydes to their corresponding acids using NAD as a cofactor. ALDH8A1 was initially proposed to mediate the biosynthesis of 9-cis-retinoic acid, but current data indicates its main role is as the aldehyde dehydrogenase of the kynurenine pathway, converting 2-aminomuconic semialdehyde to 2-aminomuconate during tryptophan catabolism. It shows strong specificity and activity for 9-cis-retinal compared to other retinoids, and contributes to pathways important for vitamin A metabolism and neuroactive compound biosynthesis. Dysfunction of related aldehyde dehydrogenases is implicated in various metabolic and neurological disorders, but ALDH8A1-specific pathologies are less well defined[1][3][4][7][8].
Not explicitly characterized for drugs; inhibitors would function by blocking oxidoreductase activity of the enzyme[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldehyde dehydrogenase 8 family member A1 (ALDH8A1).